|
The Pharmaceutical
Journal Vol 267 No 7176 p778-781 |
|
Remuneration
|
MistletoeNot effective for cancerFrom Professor E. Ernst, FRCP(Edin) Readers of the article "Complementary medicines and the treatment of cancer"1 may well get the impression that mistletoe is an effective cancer treatment. The article reports on a British Pharmaceutical Conference session where interested parties (such as the research and development director of a mistletoe product manufacturer) reported about the benefits of this herbal cancer therapy. Surprisingly, a systematic review of clinical trials2 was quoted to support the alleged efficacy of mistletoe. Here is the direct quote from the conclusion of this systematic review "mistletoe preparations cannot be recommended in the treatment of cancer patients except in clinical trials".2 Equally surprising is the fact that the recent and most rigorous study yet of mistletoe3 was not mentioned. Needless to say, this study demonstrated no benefit of adjuvant mistletoe therapy for head and neck cancer in terms of survival or quality of life. I think that, vis-à-vis this and other evidence,4 pharmacists should not be led to believe that mistletoe is of proven effectiveness for cancer patients.
E. Ernst |
||
|
Previous Topic (The elderly) |
Home | Journals | News | Notice-board | Search | Jobs Classifieds | Site
Map | Contact us
©The Pharmaceutical Journal